Retinal Vein Occlusion
Conditions
Interventions
Observation group:Observational studies do not involve intervention
Sponsors
Shanghai General Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Qualified participants selected for this study must meet all of the following criteria: 1. Patients diagnosed with RVO-ME receiving anti VEGF treatment through previous fundus examination (aged 18-80 years) 2. Best corrected visual acuity (BCVA) after anti VEGF treatment (Snellen) 20/32 to 20/400 3. Retinal fovea thickness (CST) < 320 µ M (Heidelberg OCT, CST < 300 for other models) µ M) 4. Able to accept follow-up between 12 months 5. Includes OCT image data of patients before treatment
Exclusion criteria
Exclusion criteria: Subjects who meet any of the following criteria are not eligible to be enrolled in this study. 1. Retinal vein occlusion patients with severe cardiovascular and cerebrovascular diseases 2. Pregnant women and lactating patients, children, mental disorders, and individuals with cognitive impairment 3. Iritis discovered under slit lamp, severe ischemic retinopathy 4. RVO-ME patients who received intravitreal corticosteroid injection or laser therapy within the first 6 months of the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ellipsoid crack in OCT images;OCTA Blood flow diameter index at 9mm on the temporal side of the parafovea; | — |
Secondary
| Measure | Time frame |
|---|---|
| Image phenotype information of OCT image markers;Thickness information of various OCT retinal zones;Ischemic imaging phenotype information; | — |
Countries
China
Contacts
Public ContactYupeng Xu
Shanghai General Hospital
Outcome results
None listed